Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis

Heart Rhythm. 2014 Jan;11(1):158-62. doi: 10.1016/j.hrthm.2013.10.026. Epub 2013 Oct 10.
No abstract available

Keywords: AL; ATP; ATTR; Cardiac amyloidosis; EMD; ICD; Implantable cardioverter-defibrillator; LVEF; N-terminal pro–brain natriuretic peptide; NSVT; NT-proBNP; SCD; Sudden cardiac death; VF; VT; Ventricular tachycardia; antitachycardia pacing; electromechanical dissociation; implantable cardioverter-defibrillator; left ventricular ejection fraction; light-chain amyloidosis; nonsustained ventricular tachycardia; sudden cardiac death; transthyretin amyloidosis; ventricular fibrillation; ventricular tachycardia.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyloidosis / complications
  • Amyloidosis / physiopathology
  • Amyloidosis / therapy*
  • California / epidemiology
  • Cardiomyopathies / complications
  • Cardiomyopathies / physiopathology
  • Cardiomyopathies / therapy*
  • Death, Sudden, Cardiac / epidemiology
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Survival Rate / trends
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / mortality
  • Tachycardia, Ventricular / therapy*